Search Results - "Gates, Leah A."

  • Showing 1 - 14 results of 14
Refine Results
  1. 1

    Histone Marks in the ‘Driver’s Seat’: Functional Roles in Steering the Transcription Cycle by Gates, Leah A., Foulds, Charles E., O’Malley, Bert W.

    “…Particular chromatin modifications are associated with different states of gene transcription, yet our understanding of which modifications are causal…”
    Get full text
    Journal Article
  2. 2

    In situ chromatin interactomics using a chemical bait and trap approach by Burton, Antony J., Haugbro, Michael, Gates, Leah A., Bagert, John D., Allis, C. David, Muir, Tom W.

    Published in Nature chemistry (01-06-2020)
    “…Elucidating the physiological binding partners of histone post-translational modifications (hPTMs) is key to understanding fundamental epigenetic regulatory…”
    Get full text
    Journal Article
  3. 3

    Coactivator-Dependent Oscillation of Chromatin Accessibility Dictates Circadian Gene Amplitude via REV-ERB Loading by Zhu, Bokai, Gates, Leah A., Stashi, Erin, Dasgupta, Subhamoy, Gonzales, Naomi, Dean, Adam, Dacso, Clifford C., York, Brian, O’Malley, Bert W.

    Published in Molecular cell (03-12-2015)
    “…A central mechanism for controlling circadian gene amplitude remains elusive. We present evidence for a “facilitated repression (FR)” model that functions as…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Acetylation on histone H3 lysine 9 mediates a switch from transcription initiation to elongation by Gates, Leah A., Shi, Jiejun, Rohira, Aarti D., Feng, Qin, Zhu, Bokai, Bedford, Mark T., Sagum, Cari A., Jung, Sung Yun, Qin, Jun, Tsai, Ming-Jer, Tsai, Sophia Y., Li, Wei, Foulds, Charles E., O'Malley, Bert W.

    Published in The Journal of biological chemistry (01-09-2017)
    “…The transition from transcription initiation to elongation is a key regulatory step in gene expression, which requires RNA polymerase II (pol II) to escape…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Crosstalk between histone modifications indicates that inhibition of arginine methyltransferase CARM1 activity reverses HIV latency by Zhang, Zheng, Nikolai, Bryan C, Gates, Leah A, Jung, Sung Yun, Siwak, Edward B, He, Bin, Rice, Andrew P, O'Malley, Bert W, Feng, Qin

    Published in Nucleic acids research (19-09-2017)
    “…In eukaryotic cells, the gene expression status is strictly controlled by epigenetic modifications on chromatin. The repressive status of chromatin largely…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    Trapping of cis-2-butene-1,4-dial to measure furan metabolism in human liver microsomes by cytochrome P450 enzymes by Gates, Leah A, Lu, Ding, Peterson, Lisa A

    Published in Drug metabolism and disposition (01-03-2012)
    “…Furan is a liver toxicant and carcinogen in rodents. It is classified as a possible human carcinogen, but the human health effects of furan exposure remain…”
    Get full text
    Journal Article
  11. 11

    Abundant Rodent Furan-Derived Urinary Metabolites Are Associated with Tobacco Smoke Exposure in Humans by Grill, Alex E, Schmitt, Thaddeus, Gates, Leah A, Lu, Ding, Bandyopadhyay, Dipankar, Yuan, Jian-Min, Murphy, Sharon E, Peterson, Lisa A

    Published in Chemical research in toxicology (20-07-2015)
    “…Furan, a possible human carcinogen, is found in heat treated foods and tobacco smoke. Previous studies have shown that humans are capable of converting furan…”
    Get full text
    Journal Article
  12. 12

    Comparative metabolism of furan in rodent and human cryopreserved hepatocytes by Gates, Leah A, Phillips, Martin B, Matter, Brock A, Peterson, Lisa A

    Published in Drug metabolism and disposition (01-07-2014)
    “…Furan is a liver toxicant and carcinogen in rodents. Although humans are most likely exposed to furan through a variety of sources, the effect of furan…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Proteomic profiling identifies key coactivators utilized by mutant ER[alpha] proteins as potential new therapeutic targets by Gates, Leah A, Gu, Guowei, Chen, Yue, Rohira, Aa, Lei, Jonathan T, Hamilton, Ross A, Yu, Yang

    Published in Oncogene (01-08-2018)
    “…Approximately 75% of breast cancers are estrogen receptor alpha (ER[alpha])-positive and are treatable with endocrine therapies, but often patients develop…”
    Get full text
    Journal Article